Pre-earnings brief
Reports
Thu, Nov 5, 2026
Est. EPS
—
Est. revenue
—
Implied move
±18.0%
EPS beat rate
50%
DENTSPLY SIRONA Inc. (XRAY) is a leading manufacturer of dental products and technologies, serving dental professionals worldwide. With a market cap of $2 billion, the company plays a crucial role in the health care supplies sector, focusing on innovations that enhance dental care and patient outcomes.
Last quarter
In Q2-2026, DENTSPLY SIRONA reported an EPS of $0.52, significantly beating expectations of $0.36, which resulted in a 45.25% surprise. However, the stock fell 4.43% the next day, indicating mixed investor sentiment despite the strong earnings.
Management promises and guidance
EPS beat streak
1Q
EPS beat rate
50%
Avg EPS surprise
+4.57%
Avg 1-day reaction
-5.02%
Overall, expectations for DENTSPLY SIRONA's upcoming earnings are cautious, given the mixed results in previous quarters and the lack of guidance. Investors will be looking for signs of sustained profitability and growth.
Bull case
If the company can demonstrate strong revenue growth and maintain or improve its gross margins, it could signal a robust recovery and attract more investor interest.
Bear case
Conversely, if the company fails to meet earnings expectations or shows signs of declining margins, it could lead to further stock price declines, especially given the recent volatility.
The print will turn on these.
Q1
What is the expected EPS for Q3-2026?
The EPS figure will be critical in assessing the company's profitability and could significantly influence investor sentiment.
Q2
How is the company addressing supply chain challenges?
Supply chain issues can impact production and delivery, and how the company manages these challenges will be key to future revenue growth.
Est. EPS
$1.98
Est. Rev
$113.6B
Impl. Move
±4.0%
Why consensus could be wrong
The Street may be underestimating the potential for DENTSPLY SIRONA to capitalize on emerging market opportunities, which could drive unexpected revenue growth.
Supporting evidence
The company's recent innovations in dental technology could attract new customers.
Options pricing suggests a significant move, indicating that investors are anticipating more than just a typical quarter.
Past earnings surprises indicate that the company has the potential to outperform expectations.
Key risk
If EPS exceeds $0.55, it could challenge the current cautious sentiment and lead to a reevaluation of growth prospects.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around the company's ability to sustain profitability amidst market pressures and operational challenges.
Bull confirmed if
An EPS of $0.55 or higher would confirm the bull case, indicating strong demand and effective cost management.
Bear confirmed if
An EPS below $0.40 would confirm the bear case, suggesting ongoing challenges in profitability.
What the market is pricing for the move.
Implied Move
±16.21%
Historical Avg
±9.5%
The options market is pricing in a significant potential movement in the stock price, suggesting that investors are anticipating notable news or results.
Options are pricing ±18.0% while XRAY has averaged ±9.5% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
43.0%
Smart-money positioning from the most recent 13F filings.
Institutional
117.65%
of float
Insider
0.65%
of float
Holders
493
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
26,711,079 sh · $228.1M
13.40%
38.8%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If DENTSPLY SIRONA beats expectations, history suggests the stock could rise by around 1.5%, confirming a positive outlook for growth.
In line / cautious
If results are in line with expectations but management is cautious, the stock may see little movement as investors reassess their outlook.
Miss
If the company misses earnings expectations, history suggests a potential decline of around 5.17%, reflecting investor disappointment.
The lines on the call that would change the story.
Fuller & Thaler Asset Management Inc.
12,697,269 sh · $108.4M
6.37%
-0.7%
Vanguard Portfolio Management LLC
11,779,851 sh · $100.6M
5.91%
11.9%
AQR Capital Management, LLC
10,458,771 sh · $89.3M
5.25%
163.8%
State Street Corporation
9,285,298 sh · $79.3M
4.66%
28.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.